Notice Number: NOT-CA-16-048

Key Dates
Release Date: May 27, 2016

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating, effective immediately, in PA-16-288, "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)."

The following section of PA-16-288 has been updated (changes noted in italics) to reflect the participation of NCI in this FOA.

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of General Medical Sciences (NIGMS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
National Library of Medicine (NLM)
Fogarty International Center (FIC)
National Center for Complementary and Integrative Health (NCCIH)
National Center for Advancing Translational Sciences (NCATS)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)
Office of Strategic Coordination (Common Fund)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.867, 93.233, 93.837, 93.838, 93.839, 93.172, 93.866, 93.273, 93.855, 93.856, 93.846, 93.286, 93.173, 93.847, 93.279, 93.859, 93.242, 93.853, 93.361, 93.879, 93.213, 93.350, 93.351, 93.113, 93.989, 93.310, 93.313, 93.840, 93.865, 93.393, 93.394, 93.395, 93.396, 93.399

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

NCI Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]